Jefferies Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $28.3M | Buy |
87,500
+12,500
| +17% | +$3.96M | 0.24% | 69 |
|
|
2022
Q2 | $24.3M | Sell |
75,000
-30,000
| -29% | -$9.01M | 0.2% | 74 |
|
|
2022
Q1 | $30.1M | Sell |
105,000
-35,000
| -25% | -$9.01M | 0.19% | 86 |
|
|
2021
Q4 | $38.7M | Buy |
140,000
+65,000
| +87% | +$16.5M | 0.23% | 66 |
|
|
2021
Q3 | $17.3M | Buy |
75,000
+74,000
| +7,400% | +$18.3M | 0.13% | 154 |
|
|
2021
Q2 | $230K | Sell |
1,000
-25,500
| -96% | -$5.12M | ﹤0.01% | 1377 |
|
|
2021
Q1 | $4.95M | Sell |
26,500
-3,500
| -12% | -$685K | 0.04% | 386 |
|
|
2020
Q4 | $5.07M | Sell |
30,000
-45,000
| -60% | -$6.72M | 0.04% | 405 |
|
|
2020
Q3 | $11.1M | Buy |
75,000
+65,000
| +650% | +$10.1M | 0.12% | 132 |
|
|
2020
Q2 | $1.64K | Sell |
10,000
-88,700
| -90% | -$13.6M | 0.02% | 628 |
|
|
2020
Q1 | $13.7M | Buy |
98,700
+47,500
| +93% | +$6.53M | 0.15% | 105 |
|
|
2019
Q4 | $6.73M | Buy |
51,200
+35,400
| +224% | +$4.1M | 0.05% | 388 |
|
|
2019
Q3 | $1.77M | Sell |
15,800
-100
| -0.6% | -$11.1K | 0.01% | 1170 |
|
|
2019
Q2 | $1.76M | Sell |
15,900
-52,200
| -77% | -$6.15M | 0.01% | 984 |
|
|
2019
Q1 | $8.84M | Sell |
68,100
-89,400
| -57% | -$10.9M | 0.07% | 238 |
|
|
2018
Q4 | $18.2M | Sell |
157,500
-82,400
| -34% | -$9.2M | 0.15% | 99 |
|
|
2018
Q3 | $25.7M | Buy |
239,900
+145,400
| +154% | +$14.5M | 0.17% | 96 |
|
|
2018
Q2 | $8.06M | Buy |
94,500
+68,700
| +266% | +$5.64M | 0.05% | 322 |
|
|
2018
Q1 | $2M | Sell |
25,800
-21,700
| -46% | -$1.75M | 0.01% | 867 |
|
|
2017
Q4 | $4.01M | Sell |
47,500
-34,600
| -42% | -$2.94M | 0.02% | 645 |
|
|
2017
Q3 | $7.02M | Sell |
82,100
-200
| -0.2% | -$16.4K | 0.05% | 404 |
|
|
2017
Q2 | $6.77M | Sell |
82,300
-237,900
| -74% | -$19.4M | 0.05% | 399 |
|
|
2017
Q1 | $26.9M | Buy |
320,200
+195,400
| +157% | +$15.7M | 0.2% | 73 |
|
|
2016
Q4 | $9.18M | Buy |
124,800
+32,900
| +36% | +$2.45M | 0.05% | 371 |
|
|
2016
Q3 | $7.38M | Buy |
91,900
+75,400
| +457% | +$6.04M | 0.04% | 406 |
|
|
2016
Q2 | $1.3M | Buy |
16,500
+7,200
| +77% | +$542K | 0.01% | 1056 |
|
|
2016
Q1 | $670K | Sell |
9,300
-9,000
| -49% | -$681K | ﹤0.01% | 1311 |
|
|
2015
Q4 | $1.54M | Buy |
18,300
+6,200
| +51% | +$515K | 0.01% | 981 |
|
|
2015
Q3 | $1.01M | Sell |
12,100
-13,200
| -52% | -$1.11M | 0.01% | 1195 |
|
|
2015
Q2 | $2.11M | Sell |
25,300
-145,500
| -85% | -$11.1M | 0.01% | 884 |
|
|
2015
Q1 | $12.4M | Buy |
+170,800
| New | +$12.2M | 0.07% | 194 |
|
|
2014
Q4 | – | Sell |
-109,600
| Closed | -$7.11M | – | 2178 |
|
|
2014
Q3 | $7.11M | Buy |
+109,600
| New | +$6.94M | 0.05% | 322 |
|
|
2013
Q4 | – | Sell |
-15,700
| Closed | -$790K | – | 2087 |
|
|
2013
Q3 | $790K | Buy |
+15,700
| New | +$822K | 0.01% | 1016 |
|
Other funds holding LLY
Jefferies Group's LLY Position: Q3 2022 in Review
Jefferies Group reduced its Eli Lilly (LLY) stake by 25% in Q3 2022, selling an estimated $7.09M and leaving 67,267 shares worth $21.8M. The position accounts for 0.18% of the portfolio, ranked #87.
Jefferies Group first reported a position in LLY in Q2 2013 and has held it in 38 quarters since. The position peaked at $29.1M in Q2 2022. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.
- Jefferies Group held 67,267 shares of Eli Lilly worth $21.8M as of Q3 2022.
- Jefferies Group sold 22,387 Eli Lilly shares in Q3 2022, an estimated $7.09M.
- Eli Lilly made up 0.18% of Jefferies Group's portfolio in Q3 2022, its #87 holding.
- Jefferies Group first reported a position in Eli Lilly in Q2 2013 and has held it in 38 quarters since.
- Jefferies Group's Eli Lilly position peaked at $29.1M in Q2 2022.
- 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.